Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Oramed Pharmaceuticals

NASDAQ ORMP
$2.40 0.02 0.63%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 18 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

96.61M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
56.39M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.85
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
40.34M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
3.68 %

Upcoming events Oramed Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Oramed Pharmaceuticals

Stock analysis Oramed Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
256.26 8.79
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.64 25.38
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-2.80 4.40
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
2.00 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
0.23 9.54

Price change Oramed Pharmaceuticals per year

2.40$ 24.25$
Min Max

Summary analysis Oramed Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Oramed Pharmaceuticals

Revenue and net income Oramed Pharmaceuticals

All parameters

Stock news Oramed Pharmaceuticals

All news
12 January 2023 в 20:10

Oramed Pharmaceuticals Shares Crumble as Diabetes Drug Fails >ORMP

12 January 2023 в 20:10

Oramed Pharmaceuticals Shares Crumble as Diabetes Drug Fails >ORMP

12 January 2023 в 14:15

Oramed Pharmaceuticals Shares Plummet Premarket on Study Failure >ORMP

12 January 2023 в 14:10

Oramed Pharmaceuticals Shares Plummet Premarket on Study Failure >ORMP

7 October 2022 в 16:16

Oramed Pharmaceuticals Sees Positive Oral Covid-19 Vaccine Data

7 October 2022 в 16:16

Oramed Pharmaceuticals Sees Positive Oral Covid-19 Vaccine Data

7 July 2022 в 20:50

Oramed Pharmaceuticals Shares Rise 13% After Update From CEO

7 July 2022 в 20:50

Oramed Pharmaceuticals Shares Rise 13% After Update From CEO

5 January 2022 в 15:55

Oramed Pharmaceuticals Gets European Patent for Protein-Delivery Platform

5 January 2022 в 15:55

Oramed Pharmaceuticals Gets European Patent for Protein-Delivery Platform

3 November 2021 в 19:35

Oramed Pharmaceuticals Drop 11% After Direct Offering Prices

3 November 2021 в 19:35

Oramed Pharmaceuticals Drop 11% After Direct Offering Prices

About company Oramed Pharmaceuticals

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.
Address:
1185 Avenue of the Americas, New York, NY, United States, 10036
Company name: Oramed Pharmaceuticals
Issuer ticker: ORMP
ISIN: US68403P2039
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2006-04-21
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.oramed.com

On which stock exchange are Oramed Pharmaceuticals (ORMP) stocks traded?

Oramed Pharmaceuticals (ORMP) stocks are traded on NASDAQ.

What is the ticker of Oramed Pharmaceuticals stocks (ORMP)?

The stock ticker of Oramed Pharmaceuticals’s stocks or in other words, the code is ORMP. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Oramed Pharmaceuticals (ORMP) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Oramed Pharmaceuticals (ORMP) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Oramed Pharmaceuticals (ORMP) stocks traded?

Oramed Pharmaceuticals (ORMP) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Oramed Pharmaceuticals (ORMP) stocks today?

The current price of Oramed Pharmaceuticals stocks on 14.05.2024 is 2.395 dollars. per share.

What is the dynamics of Oramed Pharmaceuticals (ORMP) stocks from the beginning of the year?

Oramed Pharmaceuticals (ORMP) quotes have increased by -2.24% from the beginning of the year up to 2.395 dollars. per 1 stocks.

How much did Oramed Pharmaceuticals (ORMP) stocks increase in мае 2024?

This month Oramed Pharmaceuticals (ORMP) quotes have increased by 2.35% to 2.395 dollars. per share.

How much are Oramed Pharmaceuticals (ORMP) stocks worth?

Today, on October, 14.05.2024 Oramed Pharmaceuticals’s (ORMP) stocks cost 2.395 dollars..

What is the market capitalization of Oramed Pharmaceuticals (ORMP)?

Capitalization is the market value of Oramed Pharmaceuticals (ORMP) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 14.05.2024, the market capitalization of Oramed Pharmaceuticals (ORMP) is estimated at about 96611855 dollars.